TAK

New York Stock Exchange

Takeda Pharmaceutical Co., Ltd. · Healthcare · Pharmaceuticals

Earnings call summary →

—

Loading quote…

Highlights

Market Cap

$52.57B

PE Ratio

69.2691

EV to Ebitda

9.188

Earnings Yield

1.44%

Revenue (TTM)

$29.85B

Net Income (TTM)

$776.9M

Revenue (Annual YoY Growth)

1.92%

Revenue (Quarterly YoY Growth)

3.02%

Profit Margin

2.60%

Return on Equity

1.63%

Debt to Equity Ratio

0.635

Dividend Yield

4.00%

All fundamentals

Core10 fields›

Market Cap$52.57B

Revenue TTM$29.85B

Shares Outstanding3.16B

Float3137120191

Float Short0.45%

Days To Cover1.1525236076

Short Interest3421218.0

Institutional Ownership3.92%

Relative Strength49

GARP1569

Growth Estimates18 fields›

Revenue Growth (Annual)1.92%

Revenue Growth (Quarterly YoY)3.02%

Operating Revenue Growth (Annual)-0.001443

Operating Revenue Growth (Quarterly YoY)-0.018254

3-Year Revenue Growth-1.83%

5-Year Revenue Growth-0.14%

EPS Growth (Annual)-30.04%

EPS Growth (Quarterly YoY)339.12%

3-Year EPS Growth Rate-30.22%

5-Year EPS Growth Rate11.16%

LT EPS Growth Estimates22.54%

EBITDA Growth (Annual)4.71%

EBITDA Growth (Quarterly YoY)11.39%

CFO Growth (Annual)42.58%

CFO Growth (Quarterly YoY)-3.92%

FCF Growth (Annual)265.32%

FCF Growth (Quarterly YoY)-58.56%

Dividend Growth (Annual)-3.32%

Operations28 fields›

Revenue TTM$29.85B

Gross Margin TTM51.70%

Gross Margin (Quarterly)54.43%

R&D % of Revenue TTM15.56%

R&D Expenses TTM$4.65B

Operating Margin TTM11.79%

Operating Margin (Quarterly)16.00%

Operating Expenses TTM$11.91B

Profit Margin TTM2.60%

Profit Margin (Quarterly)8.70%

Net Income TTM$776.9M

EPS TTM0.2408

EPS (Quarterly)0.2099

EBIT Margin TTM11.79%

EBIT Margin (Quarterly)16.00%

EBITDA Margin TTM28.98%

EBITDA Margin (Quarterly)31.99%

EBITDA TTM$8.65B

CFO % of Revenue TTM21.01%

CFO % of Revenue (Quarterly)29.68%

CFO TTM$7.30B

Cash Margin7.30%

Capex % of Revenue TTM9.88%

Capital Expenditures$2.95B

FCF % of Revenue TTM13.42%

FCF % of Revenue (Quarterly)10.63%

FCF TTM$4.35B

Fundamental Score7

Efficiency6 fields›

ROE1.63%

ROA0.80%

ROIC0.98%

CROCI5.48%

Stock Comp % (Quarterly)1.50%

Stock Comp % TTM1.59%

Valuation18 fields›

P/E (TTM)69.2691

P/E Ex-Cash63.7749

P/S Forward1.827

P/CFO7.2542

P/FCF12.1699

EV/EBITDA (TTM)9.188

EV/EBITDA Forward10.6383

EV/Revenues (TTM)2.6624

EV/Revenues Forward2.7562

EV/CFO10.4164

EV/FCF (TTM)18.2661

Price To Book1.0804

Price to Tangible Book-2.1938

Earnings Yield1.44%

FCF Yield8.22%

Dividend Yield4.00%

Payout Ratio0.00%

Value Score8

Relative to Industry11 fields›

Relative Gross Margin (Quarterly)0.9999

Relative Profit Margin (Quarterly)1.6206

Relative P/E3.486

Relative P/S0.784

Relative P/B0.4378

Relative Earnings Yield0.2869

Relative Dividend Yield1.4194

Relative ROE0.118

Relative ROA0.1417

Relative ROIC0.129

Relative Debt to Equity1.0142

Liquidity15 fields›

Cash Per Share1.3226

Current Ratio1.194

Cash & ST Assets$4.18B

Total Debt$27.24B

Goodwill & Intangibles$59.13B

Total Assets$98.30B

Total Liabilities$49.54B

Shareholders Equity$48.76B

Debt to Equity0.635

Debt to Assets31.50%

Interest Expense$2.44B

Times Interest Earned1.4435

CFO to Debt (TTM)0.2303

Debt to EBITDA (TTM)3.6635

Goodwill % of Assets60.15%

Yields5 fields›

Dividend Yield4.00%

Payout Ratio0.00%

Earnings Yield1.44%

Buyback Yield1.28%

Shareholder Yield7.38%

Options Flow8 fields›

Call Volume34

Put Volume3889

Put/Call Ratio114.38235294117646

Call $ Volume720

Put $ Volume73923

Put/Call $ Ratio102.67083333333333

Call OI4152

Put OI2928